Results 71 to 80 of about 8,420 (208)

Development and Characterization of Olmesartan Medoxomil-Loaded Microspheres for Hypertension Management

open access: yesInternational Journal of Drug Delivery Technology
Our aim is to develop and assess microspheres loaded with olmesartan medoxomil, the antagonist of angiotensin II receptor which is used in hypertension treatment, for their efficacy.
D. Mali   +3 more
semanticscholar   +1 more source

Is the newest angiotensin‐receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta‐analysis

open access: yesThe Journal of Clinical Hypertension, 2021
Angiotensin‐receptor blockers are often considered insufficiently efficacious in reducing blood pressure. However, newer angiotensin‐receptor blockers may be more effective than the older ones.
Ji‐Guang Wang   +6 more
doaj   +1 more source

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

open access: yesКардиоваскулярная терапия и профилактика, 2012
Cardiovascular (CV) disease is a major factor in mortality rates around the world and contributes to more than one-third of deaths in the US. The underlying cause of CV disease is atherosclerosis, a chronic inflammatory process that is clinically ...
R. P. Mason
doaj   +1 more source

Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi‐Omics and Multi‐Modal Data Analysis

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1463-1476, December 2025.
Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu   +21 more
wiley   +1 more source

Enhancement of Solubility and Dissolution Rate of Olmesartan Medoxomil by Solid Dispersion Technique

open access: yes, 2021
The enhancement of dissolution rate and oral bioavailability of poorly soluble drugs remains one of the most challenging aspects of drug development.
Janeesha, P
core  

Pseudo‐Hypoaldosteronism Type 2 due to New Variants of KLHL3 Gene Diagnosed in an Adult Woman With Very High Sensitivity to Hydrochlorothiazide

open access: yesClinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT We report a case of pseudo‐hypoaldosteronism type 2 (PHA II) in a hypertensive 55‐year‐old woman who carried new variants of the KLHL3 gene. Hypersensitivity to hydrochlorothiazide was noted. Low dosages of hydrochlorothiazide were needed to restore potassium levels.
Massimo Giusti   +2 more
wiley   +1 more source

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL

open access: yesРоссийский кардиологический журнал, 2010
Endothelial dysfunction is the common link between cardiovascular disease risk factors and the earliest event in the cascade of incidents that results in target organ damage.
C. Ferrario
doaj  

Molecularly Imprinted Poly(Trimethylolpropane Triacrylate‐Co‐Ethylene Glycol Dimethacrylate‐Co‐Methacrylic Acid) Monolithic Sorbent for Pipette‐Tip Solid‐Phase Extraction of N‐Nitrosodimethylamine in Medicaments

open access: yesSEPARATION SCIENCE PLUS, Volume 8, Issue 9, September 2025.
ABSTRACT A novel pipette‐tip solid‐phase extraction method was developed using a molecularly imprinted monolithic sorbent composed of poly(trimethylolpropane triacrylate‐co‐ethylene glycol dimethacrylate‐co‐methacrylic acid) for the selective extraction of N‐nitrosodimethylamine from pharmaceutical formulations.
Allyson Leandro Rodrigues dos Santos   +2 more
wiley   +1 more source

Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2)

open access: yesКардиоСоматика, 2015
The article provides an overview of pleiotropic activity and clinical efficacy of one of the representatives of the class of angiotensin receptor blockers II - olmesartan medoxomil.
M. G Bubnova
doaj  

Effects of Two Allisartan Isoproxil‐Based Antihypertensive Therapies on Sexual Function and Blood Pressure in Male Hypertensive Patients: A Single‐Center, Open‐Label, and Randomized Controlled Trial

open access: yesThe Journal of Clinical Hypertension, Volume 27, Issue 9, September 2025.
ABSTRACT This study evaluated the effects of allisartan isoproxil combined with amlodipine besylate tablets (Group A+C) or metoprolol succinate extended‐release tablets (Group A+B) on sexual function and nighttime blood pressure (nBP) in 130 male patients with essential hypertension (EH). Patients were randomized to two groups.
Mingming Wang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy